Valuation : Biogen Inc.

Market Cap 3.26TCr 2.81TCr 2.64TCr 2.41TCr 4.51TCr 3,08100Cr 4.53TCr 31TCr 12TCr 1,58100Cr 12TCr 12TCr 5,09200Cr P/E 2026 *
38.1x
P/E 2027 * 19.8x
Enterprise Value 3.76TCr 3.23TCr 3.04TCr 2.78TCr 5.2TCr 3,54700Cr 5.21TCr 36TCr 14TCr 1,82000Cr 14TCr 14TCr 5,86200Cr EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.29x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+3.77%
1 week+1.06%
Current month+0.97%
1 month+5.22%
3 months+14.63%
6 months+17.05%
Current year+26.66%
1 week 183.02
Extreme 183.02
194.12
1 month 175.9
Extreme 175.9
194.12
Current year 134.7
Extreme 134.7
194.12
1 year 115.65
Extreme 115.65
194.12
3 years 99
Extreme 99
255.4
5 years 99
Extreme 99
317.45
10 years 99
Extreme 99
351.7
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+3.77%+1.06% - - 3.26TCr
-1.87%+4.22%+44.36%+0.58% 8.27TCr
-0.57%+1.27%-16.61%-35.57% 6.02TCr
-2.23%+5.48%+478.96%+33.09% 5.81TCr
-2.03%-2.62%-8.63%+27.87% 4.97TCr
-4.58%-2.73%+1.79%+159.87% 4.67TCr
-1.64%+1.07%+56.98%-17.07% 3.26TCr
-0.98%+1.91%+46.30%+100.30% 2.57TCr
-0.19%-4.74%-0.68%+194.68% 2.27TCr
-1.13%-2.45%+64.66%+108.24% 1.65TCr
Average -1.14%-0.24%+74.13%+63.55% 4.39TCr
Weighted average by Cap. -1.43%+0.74%+86.73%+42.82%

Financials

2026 *2027 *
Net sales 1.04TCr 898.71Cr 845.56Cr 772.42Cr 1.44TCr 99TCr 1.45TCr 9.99TCr 3.88TCr 51TCr 3.92TCr 3.84TCr 1,63000Cr 1.07TCr 916.96Cr 862.73Cr 788.11Cr 1.47TCr 1,00600Cr 1.48TCr 10TCr 3.96TCr 52TCr 4TCr 3.91TCr 1,66300Cr
Net income 96Cr 83Cr 78Cr 71Cr 133.35Cr 9.1TCr 133.71Cr 922.1Cr 357.82Cr 4.67TCr 361.93Cr 354.04Cr 15TCr 185.54Cr 159.66Cr 150.22Cr 137.22Cr 256.7Cr 18TCr 257.4Cr 1.78TCr 688.81Cr 8.99TCr 696.73Cr 681.53Cr 29TCr
Net Debt 493.67Cr 424.8Cr 399.68Cr 365.11Cr 683.01Cr 47TCr 684.87Cr 4.72TCr 1.83TCr 24TCr 1.85TCr 1.81TCr 77TCr 242Cr 208.24Cr 195.93Cr 178.98Cr 334.82Cr 23TCr 335.73Cr 2.32TCr 898.4Cr 12TCr 908.74Cr 888.92Cr 38TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
04/26/04 €189.92 +3.77% 125
02/26/02 €183.02 -1.80% 100
01/26/01 €186.38 -0.91% 584
31/26/31 €188.10 +0.10% 16
28/26/28 €187.92 -1.11% 28
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
220.83USD
Average target price
236.87USD
Spread / Average Target
+7.26%

Quarterly revenue - Rate of surprise